annual D&A:
$3.26B+$408.14M(+14.31%)Summary
- As of today (August 20, 2025), GSK annual depreciation & amortization is $3.26 billion, with the most recent change of +$408.14 million (+14.31%) on December 31, 2024.
- During the last 3 years, GSK annual D&A has risen by +$341.30 million (+11.69%).
- GSK annual D&A is now at all-time high.
Performance
GSK Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.53B+$488.99M(+47.18%)Summary
- As of today (August 20, 2025), GSK quarterly depreciation & amortization is $1.53 billion, with the most recent change of +$488.99 million (+47.18%) on June 30, 2025.
- Over the past year, GSK quarterly D&A has increased by +$720.15 million (+89.43%).
- GSK quarterly D&A is now -55.49% below its all-time high of $3.43 billion, reached on December 31, 2020.
Performance
GSK quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$4.91B+$720.15M(+17.18%)Summary
- As of today (August 20, 2025), GSK TTM depreciation & amortization is $4.91 billion, with the most recent change of +$720.15 million (+17.18%) on June 30, 2025.
- Over the past year, GSK TTM D&A has increased by +$1.24 billion (+33.66%).
- GSK TTM D&A is now -17.45% below its all-time high of $5.95 billion, reached on September 30, 2021.
Performance
GSK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GSK Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.3% | +89.4% | +33.7% |
| 3 y3 years | +11.7% | +29.9% | +45.0% |
| 5 y5 years | +9.5% | +203.8% | +694.3% |
GSK Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.3% | at high | +2143.6% | at high | +143.1% |
| 5 y | 5-year | at high | +23.3% | -55.5% | +203.8% | -17.4% | +694.3% |
| alltime | all time | at high | +1066.7% | -55.5% | +203.8% | -17.4% | +694.3% |
GSK Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.53B(+47.2%) | $4.91B(+17.2%) |
| Mar 2025 | - | $1.04B(-9.0%) | $4.19B(+8.8%) |
| Dec 2024 | $3.26B(+14.3%) | $1.14B(-6.0%) | $3.85B(-7.0%) |
| Sep 2024 | - | $1.21B(+50.4%) | $4.14B(+12.7%) |
| Jun 2024 | - | $805.25M(+15.7%) | $3.68B(+6.7%) |
| Mar 2024 | - | $696.10M(-51.3%) | $3.44B(-2.3%) |
| Dec 2023 | $2.85B(+7.8%) | $1.43B(+91.9%) | $3.52B(+74.4%) |
| Sep 2023 | - | $744.57M(+29.9%) | $2.02B(-16.6%) |
| Jun 2023 | - | $573.18M(-26.3%) | $2.42B(-19.9%) |
| Mar 2023 | - | $777.63M(-1141.8%) | $3.02B(+7.7%) |
| Dec 2022 | $2.64B(-9.4%) | -$74.64M(-106.5%) | $2.81B(-14.2%) |
| Sep 2022 | - | $1.15B(-2.3%) | $3.27B(-3.4%) |
| Jun 2022 | - | $1.17B(+109.5%) | $3.39B(+13.8%) |
| Mar 2022 | - | $560.55M(+43.1%) | $2.98B(+2.2%) |
| Dec 2021 | $2.92B(-3.2%) | $391.69M(-68.9%) | $2.91B(-51.0%) |
| Sep 2021 | - | $1.26B(+65.1%) | $5.95B(+8.3%) |
| Jun 2021 | - | $763.80M(+53.4%) | $5.50B(+68.5%) |
| Mar 2021 | - | $497.78M(-85.5%) | $3.26B(+8.3%) |
| Dec 2020 | $3.01B(+1.3%) | $3.43B(+324.6%) | $3.01B(-576.4%) |
| Sep 2020 | - | $807.17M(-154.9%) | -$632.38M(-23.5%) |
| Jun 2020 | - | -$1.47B(-693.0%) | -$826.51M(-149.9%) |
| Mar 2020 | - | $247.87M(-213.9%) | $1.66B(-43.8%) |
| Dec 2019 | $2.98B(+20.3%) | -$217.67M(-135.5%) | $2.95B(-27.8%) |
| Sep 2019 | - | $613.04M(-39.5%) | $4.08B(-0.7%) |
| Jun 2019 | - | $1.01B(-34.2%) | $4.11B(+22.1%) |
| Mar 2019 | - | $1.54B(+68.2%) | $3.37B(+35.1%) |
| Dec 2018 | $2.47B(-0.0%) | $916.03M(+43.0%) | $2.49B(+83.1%) |
| Sep 2018 | - | $640.54M(+137.6%) | $1.36B(-16.2%) |
| Jun 2018 | - | $269.56M(-59.5%) | $1.62B(-40.5%) |
| Mar 2018 | - | $665.18M(-409.4%) | $2.73B(+10.6%) |
| Dec 2017 | $2.48B(+3.7%) | -$215.02M(-123.8%) | $2.47B(-29.1%) |
| Sep 2017 | - | $904.38M(-34.2%) | $3.48B(+24.0%) |
| Jun 2017 | - | $1.37B(+240.3%) | $2.81B(+40.3%) |
| Mar 2017 | - | $403.96M(-49.3%) | $2.00B(-16.2%) |
| Dec 2016 | $2.39B(-4.1%) | $797.42M(+246.2%) | $2.39B(+17.6%) |
| Sep 2016 | - | $230.30M(-59.5%) | $2.03B(-6.1%) |
| Jun 2016 | - | $569.25M(-28.0%) | $2.16B(-12.8%) |
| Mar 2016 | - | $790.39M(+79.7%) | $2.48B(-0.9%) |
| Dec 2015 | $2.49B(+1.9%) | $439.76M(+21.5%) | $2.50B(+8.9%) |
| Sep 2015 | - | $361.95M(-59.2%) | $2.30B(-10.4%) |
| Jun 2015 | - | $886.29M(+9.1%) | $2.56B(+10.7%) |
| Mar 2015 | - | $812.70M(+244.4%) | $2.32B(-5.7%) |
| Dec 2014 | $2.44B(+10.3%) | $235.97M(-62.5%) | $2.46B(+51.6%) |
| Sep 2014 | - | $629.96M(-1.2%) | $1.62B(-22.9%) |
| Jun 2014 | - | $637.41M(-33.1%) | $2.10B(-8.6%) |
| Mar 2014 | - | $952.41M(-258.8%) | $2.30B(+3.9%) |
| Dec 2013 | $2.21B(-3.3%) | -$599.76M(-153.9%) | $2.21B(-43.6%) |
| Sep 2013 | - | $1.11B(+33.1%) | $3.93B(+21.6%) |
| Jun 2013 | - | $835.57M(-3.6%) | $3.23B(+15.9%) |
| Mar 2013 | - | $866.92M(-22.0%) | $2.79B(+21.1%) |
| Dec 2012 | $2.29B(+0.4%) | $1.11B(+167.5%) | $2.30B(+45.5%) |
| Sep 2012 | - | $415.66M(+6.0%) | $1.58B(-24.8%) |
| Jun 2012 | - | $392.03M(+2.7%) | $2.10B(-14.6%) |
| Mar 2012 | - | $381.86M(-2.8%) | $2.46B(+7.6%) |
| Dec 2011 | $2.28B | $392.72M(-58.1%) | $2.29B(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $936.91M(+24.4%) | $2.20B(+2.7%) |
| Jun 2011 | - | $753.01M(+261.5%) | $2.14B(+3.0%) |
| Mar 2011 | - | $208.29M(-30.7%) | $2.08B(-19.8%) |
| Dec 2010 | $2.59B(+5.7%) | $300.70M(-65.8%) | $2.59B(-7.4%) |
| Sep 2010 | - | $880.07M(+27.6%) | $2.80B(+3.4%) |
| Jun 2010 | - | $689.76M(-4.3%) | $2.71B(+17.3%) |
| Mar 2010 | - | $721.01M(+42.3%) | $2.31B(-5.8%) |
| Dec 2009 | $2.45B(+8.2%) | $506.76M(-35.8%) | $2.45B(+7.5%) |
| Sep 2009 | - | $788.84M(+170.7%) | $2.28B(+2.0%) |
| Jun 2009 | - | $291.43M(-66.3%) | $2.23B(-11.1%) |
| Mar 2009 | - | $864.38M(+158.0%) | $2.51B(+10.9%) |
| Dec 2008 | $2.27B(+10.8%) | $335.03M(-54.9%) | $2.27B(+5.1%) |
| Sep 2008 | - | $743.52M(+30.2%) | $2.16B(-2.4%) |
| Jun 2008 | - | $570.84M(-7.4%) | $2.21B(+3.5%) |
| Mar 2008 | - | $616.35M(+173.4%) | $2.13B(+3.9%) |
| Dec 2007 | $2.05B(+16.0%) | $225.41M(-71.7%) | $2.05B(+6.4%) |
| Sep 2007 | - | $795.92M(+60.4%) | $1.93B(+11.6%) |
| Jun 2007 | - | $496.25M(-7.3%) | $1.73B(-8.8%) |
| Mar 2007 | - | $535.50M(+420.9%) | $1.90B(+7.3%) |
| Dec 2006 | $1.76B(+7.4%) | $102.80M(-82.7%) | $1.77B(-16.4%) |
| Sep 2006 | - | $594.52M(-10.3%) | $2.11B(+8.8%) |
| Jun 2006 | - | $662.51M(+63.0%) | $1.94B(+9.6%) |
| Mar 2006 | - | $406.44M(-9.7%) | $1.77B(+7.8%) |
| Dec 2005 | $1.64B(+4.4%) | $450.23M(+6.4%) | $1.64B(+55.1%) |
| Sep 2005 | - | $423.25M(-14.1%) | $1.06B(-13.5%) |
| Jun 2005 | - | $492.77M(+77.3%) | $1.23B(-4.0%) |
| Mar 2005 | - | $277.96M(-308.0%) | $1.28B(-18.9%) |
| Dec 2004 | $1.57B(+12.0%) | -$133.62M(-122.7%) | $1.57B(-18.7%) |
| Sep 2004 | - | $589.10M(+8.4%) | $1.94B(-1.6%) |
| Jun 2004 | - | $543.35M(-5.5%) | $1.97B(+14.4%) |
| Mar 2004 | - | $575.00M(+152.2%) | $1.72B(+22.3%) |
| Dec 2003 | $1.40B(+11.2%) | $228.01M(-63.2%) | $1.40B(-1.5%) |
| Sep 2003 | - | $619.59M(+109.3%) | $1.43B(+19.0%) |
| Jun 2003 | - | $296.00M(+13.3%) | $1.20B(+4.8%) |
| Mar 2003 | - | $261.25M(+4.6%) | $1.14B(-7.6%) |
| Dec 2002 | $1.26B(+8.2%) | $249.87M(-36.2%) | $1.24B(-10.1%) |
| Sep 2002 | - | $391.83M(+62.2%) | $1.38B(+5.0%) |
| Jun 2002 | - | $241.50M(-32.0%) | $1.31B(-0.0%) |
| Mar 2002 | - | $355.16M(-8.6%) | $1.31B(+12.0%) |
| Dec 2001 | $1.17B(-0.1%) | $388.41M(+19.1%) | $1.17B(-38.3%) |
| Sep 2001 | - | $326.19M(+35.1%) | $1.90B(+40.4%) |
| Jun 2001 | - | $241.50M(+12.5%) | $1.35B(+29.4%) |
| Mar 2001 | - | $214.63M(-80.7%) | $1.04B(-6.2%) |
| Dec 2000 | $1.17B(+2.5%) | $1.11B(-608.7%) | $1.11B(>+9900.0%) |
| Sep 2000 | - | -$219.01M(+236.1%) | $100.00(-100.0%) |
| Jun 2000 | - | -$65.17M(-122.9%) | $219.01M(-22.9%) |
| Mar 2000 | - | $284.19M | $284.19M |
| Dec 1999 | $1.14B(+85.9%) | - | - |
| Dec 1998 | $613.19M(+0.4%) | - | - |
| Dec 1997 | $610.84M(-4.5%) | - | - |
| Dec 1996 | $639.67M(-24.0%) | - | - |
| Dec 1995 | $841.17M(+99.2%) | - | - |
| Jun 1994 | $422.21M(+16.7%) | - | - |
| Jun 1993 | $361.84M(+7.8%) | - | - |
| Jun 1992 | $335.72M(+20.2%) | - | - |
| Jun 1991 | $279.40M | - | - |
FAQ
- What is GSK plc annual depreciation & amortization?
- What is the all time high annual D&A for GSK plc?
- What is GSK plc annual D&A year-on-year change?
- What is GSK plc quarterly depreciation & amortization?
- What is the all time high quarterly D&A for GSK plc?
- What is GSK plc quarterly D&A year-on-year change?
- What is GSK plc TTM depreciation & amortization?
- What is the all time high TTM D&A for GSK plc?
- What is GSK plc TTM D&A year-on-year change?
What is GSK plc annual depreciation & amortization?
The current annual D&A of GSK is $3.26B
What is the all time high annual D&A for GSK plc?
GSK plc all-time high annual depreciation & amortization is $3.26B
What is GSK plc annual D&A year-on-year change?
Over the past year, GSK annual depreciation & amortization has changed by +$408.14M (+14.31%)
What is GSK plc quarterly depreciation & amortization?
The current quarterly D&A of GSK is $1.53B
What is the all time high quarterly D&A for GSK plc?
GSK plc all-time high quarterly depreciation & amortization is $3.43B
What is GSK plc quarterly D&A year-on-year change?
Over the past year, GSK quarterly depreciation & amortization has changed by +$720.15M (+89.43%)
What is GSK plc TTM depreciation & amortization?
The current TTM D&A of GSK is $4.91B
What is the all time high TTM D&A for GSK plc?
GSK plc all-time high TTM depreciation & amortization is $5.95B
What is GSK plc TTM D&A year-on-year change?
Over the past year, GSK TTM depreciation & amortization has changed by +$1.24B (+33.66%)